On July 28, 2021 Xphyto Therapeutics (XPHY.C) announced that its acquisition target, 3a-diagnostics GmbH, has identified the first saliva-activated in-mouth biosensor candidates for the detection of a COVID-19 infection….
COVID-19 kits
XPhyto Therapeutics (XPHY.C) has delivered 2,000 of its rapid, 25-minute polymerase chain reaction (PCR) tests, COVID-ID Lab, to an established medical distributor in Israel for clinical evaluation for the…
XPhyto (XPHY.C) has successfully completed their corporate rebranding and launched a new website. “The company is excited to introduce a fresh look at such a pivotal point in our…
Victory Square Technologies (VST.C) has received the declaration of conformity from the European Union (EU), designating that their COVID-19 rapid test is in compliance with all the requirements of…
Empower Clinics’ (CBDT.C) Kai Laboratory will launch their FDA approved, at-home or work saliva COVID-19 RT-PCR test on December 15, according to a press release. The KAI Saliva Test…
Empower Clinics (CBDT.C) announced today that they have received a purchase order for 9,000 of their RT-PCR COVID-19 detection tests, which will be processed over the next four months…